Globe Life Inc. (DE:TMJ)
NYSE:TMJ
TMJ Stock Chart & Stats
€126.20
€0.00(0.00%)
At close: 4:00 PM EST
€126.20
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€99.50 - €138.10
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€10.72B
Enterprise Value€14.42B
Total Cash (Recent Filing)€439.00M
Total Debt (Recent Filing)€2.78B
Price to Earnings (P/E)10.6
Beta0.13
Next Earnings
Jul 29, 2026EPS Estimate
3.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)14.70
Shares Outstanding77,644,760
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.51
Price to Book (P/B)1.89
Price to Sales (P/S)1.89
P/FCF Ratio9.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€149.70Price Target Upside18.62% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
EPS Forecast (FY)13.43
Revenue Forecast (FY)€5.51B
Bulls Say, Bears Say
Bulls Say
Underwriting Margins & Premium GrowthConsistent premium growth and robust life underwriting margins (~41% Q1) with improving health sales support durable underwriting profitability. Recurring premium streams and resilient margins sustain earnings and reserve funding over multiple years, limiting reliance on volatile investment gains.
Disciplined Capital Returns And BuybacksMaterial dividend increase and aggressive repurchase program reflect strong internal cash priorities and management confidence. Sustained, disciplined capital returns can boost EPS, signal prudent capital allocation, and align management incentives with long‑term shareholder value.
Conservative Capital & Solvency MetricsRBC well above the 300% target and historically conservative leverage provide a durable solvency buffer against adverse claims or market shocks. This excess capital underpins growth initiatives, investment purchases, and ongoing shareholder returns without immediate solvency strain.
Bears Say
Elevated Lapse Rates & Agent Retention PressurePersistently higher lapses and weakening producer retention reduce policy persistency and lifetime premium yield, pressuring future renewal income. Recruiting and compensation changes take months to reverse trends, implying multi-quarter risk to acquisition economics and sustainable margin performance.
Material Unrealized Long-duration Bond LossesLarge mark-to-market losses on long-dated bonds reduce reported equity and create sensitivity to rate moves. While management plans to hold to maturity, these losses constrain balance-sheet flexibility and could pressure capital ratios or hedging choices if rates remain elevated.
Weak Free Cash Flow MomentumDeclining free cash flow momentum and inconsistent cash coverage of debt reduce the firmness of internally generated capital to fund buybacks or absorb shocks. Over a multi-quarter horizon, weaker FCF growth limits flexibility for sustained payout increases or opportunistic investment without relying on capital actions.
Globe Life News
TMJ FAQ
What was Globe Life Inc.’s price range in the past 12 months?
Globe Life Inc. lowest stock price was €99.50 and its highest was €138.10 in the past 12 months.
What is Globe Life Inc.’s market cap?
Globe Life Inc.’s market cap is €10.72B.
When is Globe Life Inc.’s upcoming earnings report date?
Globe Life Inc.’s upcoming earnings report date is Jul 29, 2026 which is in 49 days.
How were Globe Life Inc.’s earnings last quarter?
Globe Life Inc. released its earnings results on Apr 22, 2026. The company reported €2.948 earnings per share for the quarter, missing the consensus estimate of €2.986 by -€0.038.
Is Globe Life Inc. overvalued?
According to Wall Street analysts Globe Life Inc.’s price is currently Undervalued.
Does Globe Life Inc. pay dividends?
Globe Life Inc. does not currently pay dividends.
What is Globe Life Inc.’s EPS estimate?
Globe Life Inc.’s EPS estimate is 3.16.
How many shares outstanding does Globe Life Inc. have?
Globe Life Inc. has 77,644,760 shares outstanding.
What happened to Globe Life Inc.’s price movement after its last earnings report?
Globe Life Inc. reported an EPS of €2.948 in its last earnings report, missing expectations of €2.986. Following the earnings report the stock price went up 0.627%.
Which hedge fund is a major shareholder of Globe Life Inc.?
Currently, no hedge funds are holding shares in DE:TMJ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Globe Life Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€149.70 (18.62% Upside)
€149.70 (18.62% Upside)
Blogger Sentiment
Bullish
DE:TMJ Sentiment 70%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth €22.4M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
30.21%
12-Months-Change
Fundamentals
Return on Equity
20.32%
Trailing 12-Months
Asset Growth
4.24%
Trailing 12-Months
Company Description
Globe Life Inc.
Globe Life Inc. delivers diverse life insurance and supplementary health coverage, alongside annuity products, targeting households in the lower-middle to middle-income brackets throughout the United States. The company's operations are structured into four key segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. Its offerings encompass whole life, term life, and other life protection plans; supplemental health benefits like Medicare supplements, critical illness, and accident policies; and both single-premium and flexible-premium deferred annuities. Founded in 1979 and headquartered in McKinney, Texas, the enterprise rebranded from Torchmark Corporation to Globe Life Inc. in August 2019.
TMJ Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a predominantly positive operational and financial picture: double-digit net operating EPS growth, strong year-over-year sales (notably +58% health net sales), solid investment yields and disciplined capital returns including an increased dividend and accelerated buybacks. Management provided constructive guidance and highlighted a meaningful Q3 remeasurement tailwind ($70M–$110M pre-tax). Challenges noted—elevated lapse rates, a decline in producing agent count at American Income, Q1 health seasonality, rising administrative expenses and an unrealized investment loss position—are being actively managed through compensation changes, AI/technology investments, rate increases in health and conservative investment/holding strategies. Overall, the positive results, strengthened guidance, and shareholder-friendly capital deployment outweigh the manageable operational headwinds described.View all DE:TMJ earnings summariesTMJ Revenue Breakdown
56.44% Life
24.31% Health
0.00% Annuity
19.65% Investment
<0.01% Corporate & Other
-0.42% Realized gains (losses)
TMJ Stock 12 Month Forecast
Average Price Target
€149.70
▲(18.62% Upside)
Technical Analysis
Lincoln National
―
Primerica
―
Unum Group
―
Jackson Financial Incorporation
―
F&G Annuities & Life Inc
―
Options Prices
Currently, No data available
---